National Securities Upgrades ShotSpotter (SSTI) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SSTI Hot Sheet
Price: $8.33 -0.36%
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
National Securities analyst Matthew Galinko upgraded ShotSpotter (NASDAQ: SSTI) from Neutral to Buy with a price target of $34.00 (from $44.00).
For an analyst ratings summary and ratings history on ShotSpotter click here. For more ratings news on ShotSpotter click here.
Shares of ShotSpotter closed at $20.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK304 at Goldman Sachs
- Expedia (EXPE) PT Raised to $320 at Goldman Sachs
- Kotak Upgrades Biocon Ltd (BIOS:IN) to Add (2)
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
